ABSTRACT
Abstract Background: Sjögren's Syndrome compromises the exocrine function, producing xerostomia and xerophthalmia. It can appear as an isolated condition or associated with other autoimmune diseases (polyautoimmunity). The Unstimulated Salivary Flow rate (UWSF) is used to quantify saliva production. There is no objective evidence to differentiate the values in patients with Sjögren's versus healthy people or patients with non-Sjögren's sicca. The objective of the present review was to evaluate the UWSF in patients with Sjögren's syndrome in comparison to controls (healthy and non-Sjögren's sicca patients). Methods: A systematic literature review was carried out (PRISMA guidelines). Analytical observational studies of cases and controls, cross-sectional studies, cohort studies and randomized clinical trials (including healthy controls) were considered. The Medline/OVID, Lilacs, Embase, and Cochrane/OVID databases were consulted. MeSH, DeCS, keywords, and Boolean operators were used. The meta-analysis (RevMan 5.2) was done through the random-effects model [mean difference (MD)]. Level and quality of evidence were evaluated by the Oxford Center Levels of Evidence and Joanna Brigs list respectively. Results: Thirty-two articles were included (20 were case-control studies,6 were cross-sectional,2 prospective cohort,2 retrospective cohort, and2 studies were abstracts) and 28 were meta-analyzed. The unstimulated whole salivary flow rate in the Sjögren's group was lower than in controls (healthy and patients with non-Sjögren Sicca syndrome) (MD-0.18 ml/min; 95% CI, −0.24 to −0.13; chi2-P-value <0.00001). Heterogeneity was 97% and there was publication bias (funnel plot). The level of evidence was mostly3 or 4. The quality of evidence was met (97% of items valued). Conclusion: For the first time, the unstimulated whole salivary flow rate is found to be lower in patients with Sjögren's syndrome compared to controls (healthy and non-SS sicca) through a meta-analysis. (AU)
Subject(s)
Humans , Salivary Glands/metabolism , Xerostomia/metabolism , Sjogren's Syndrome/physiopathology , AutoimmunityABSTRACT
Este articulo reflexiona sobre el impacto del cáncer en la sociedad, tomando la evaluación de la incidencia y tasa de mortalidad según el informe de GLOBANCAN 2012; así mismo menciona los factores de riesgo modificables en dicha patología, y su comportamiento al año 2020, se dan a conocer las estrategias mundiales y nacionales para combatir sus complicaciones. De igual manera, se expresa la importancia de continuar trabajando en este tema, haciendo énfasis en los factores modificables, la detección temprana y el tratamiento teniendo en cuenta que a pesar de los avances tanto tecnológicos como en estrategias en salud continúa siendo una gran problemática en salud pública. [Cajamarca Barón JH. El cáncer y su impacto en salud pública.
This article will try to mention the impact of cancer on society, that assessed by the incidence and mortality rate as reported by GLOBANCAN 2012, also mention the modifiable risk factors for this disease, and its him behavior at 2020, showing global and national strategies to combat its complications, achieving an analysis of the importance of further work on this issue, emphasizing those in modifiable factors, early detection and treatment considering that despite the technological and health advances strategies remains a major health problem. [Cajamarca Barón JH. Cancer and its impact on public health.
Este artigo abordará o impacto do câncer na sociedade, avaliado pela taxa de incidência e mortalidade, conforme relatado por GLOBANCAN 2012. Mostrará também os fatores de risco modificáveis para a doença, e seu comportamento até 2020, mostrando estratégias globais e nacionais para lutar contra suas complicações, alcançando uma análise da importância de prosseguir com os trabalhos sobre esta questão. Com ênfase nos fatores modificáveis, detecção precoce e tratamento, considerando que, a pesar da tecnologia e dos avanços estratégicos para combate da patologia, esta continua a ser um grave problema de saúde. [Cajamarca Barón JH. O impacto do câncer na saúde pública.